Magellan(MAGE)
Focus: Magellan is a public biotechnology company focused on stem cell-derived therapies for osteoarthritis and musculoskeletal disorders, operating from Wallace, Idaho with a highly specialized pipeline.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
229+230 this month
Hot — 235 jobs added in 30d
Net +230 (235 new, 5 removed). Aggressive expansion phase.
Should You Work at Magellan?
AI assessmentHigh-risk, early-stage opportunity suitable only for mission-driven scientists willing to accept significant financial instability in exchange for deep cell therapy involvement.
Why Work Here
- Lead a Phase 3 program in allogeneic mesenchymal stem cells for knee osteoarthritis with clear regulatory pathway
- Opportunity to shape early-stage company culture and strategy as a public entity with focused therapeutic focus
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Mightier video games
Emotional DysregulationClinical Trials (1)
NCT04732806A Mightier Healthcare System
N/AHelp build intelligence for Magellan
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.